's Chart of the Day - CryoPort
Related Stocks
 CYRX - Cryoport Inc
The Chart of the Day belongs to CryoPort (CYRX).  I found the specialty shipping stock by using Barchart to sort today's Top Stocks to Ownlist first for the highest Weighted Alpha, then again for technical buy signals of 80% or more.  Since the Trend Spotter signaled a buy on 5/10 the stock gained 174.75%.

CryoPort, Inc. operates as a provider of shipping solutions comprising cold chain frozen shipping system for transporting biological, environmental and other temperature sensitive materials at temperatures below minus 150' Celsius. Its products include CryoPort Express Shippers, cryogenic dry vapor shippers capable of maintaining cryogenic temperatures; biological material holders for the shipment of infectious or dangerous goods; CryoPort Express System to programmatically manage order entry and various aspects of shipping operations; and CryoPort Express Analytics, to monitor shipment performance metrics and to evaluate temperature-monitoring data collected by the data logger during shipment. The Company's products find their application in the transportation of live cell pharmaceutical products, such as cancer vaccines, diagnostic materials, semen and embryos, and infectious substances. CryoPort, Inc. is based in Lake Forest, California.

The status of Barchart's Opinion trading systems are listed below. Please note that the Barchart Opinion indicators are updated live during the session every 10 minutes and can therefore change during the day as the market fluctuates. The indicator numbers shown below therefore may not match what you see live on the web site when you read this report.

Barchart technical indicators:

  • 96% technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 8 new highs and up 32.92% in the last month
  • Relative Strength Index 76.14%
  • Technical support level at 7.14
  • Recently traded at 7.59 with a 50 day moving average of 5.52
Fundamental factors:
  • Market Cap $182 million
  • Revenue expected to grow 94.90% next year
  • Wall Street analysts issued 2 strong buy and 1 buy recommendation on the stock